Form 483

Magellan Diagnostics, Inc. Form 483, 2025-08-26

FDA issued a Form 483 to Magellan Diagnostics, Inc. on 2025-08-26 with 9 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health9 observations

Magellan Diagnostics, Inc. · North Billerica, United States · Issued August 26, 2025

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Aug 2025
21 CFR 803.17(a)(1)

Lack of System for Event Evaluations

Cited by Sunita Pandey

26 Aug 2025
21 CFR 803.50(a)(2)

Individual Report of Malfunction

Cited by Sunita Pandey

26 Aug 2025
21 CFR 806.10(a)(2)

Report of violation of the Act (see 803.52(e)(9))

Cited by Sunita Pandey

26 Aug 2025
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Sunita Pandey

26 Aug 2025
21 CFR 820.250(b)

Sampling plans

Cited by Sunita Pandey

Inspected site

MDMagellan Diagnostics, Inc.North Billerica, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.17(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 803.50(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 806.10(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.250(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(f)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x
21 CFR 820.80(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 9 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere